Brief title: FLO
Design: Oxaliplatin, 5-fluorouracil and leucovorin every two weeks in patients with advanced gastric cancer; preliminary results of a multicenter, phase II study.
No of patients: 40
Status: Completed

Patients with measurable locally advanced or metastatic gastric cancer and no prior chemotherapy were eligible for the study.

Prof. Dr. S.E. Al-Batran
Institut für Klinisch-Onkologische Forschung
Krankenhaus Nordwest GmbH
Steinbacher Hohl 2-26
60488 Frankfurt/Main